Ray Therapeutics has received PRIME designation from the EMA for its RTx-015 gene therapy to treat retinitis pigmentosa (RP).
Ray Therapeutics receives EMA PRIME status for gene therapy
Ray Therapeutics has received PRIME designation from the EMA for its RTx-015 gene therapy to treat retinitis pigmentosa (RP).
The resumption of the Oracle Health implementation at the U.S. Department of Veterans Affairs has so far been “phenomenal,” the agency’s secretary told lawmakers. The VA …
The oldest millennials are turning 45 this year. The oldest Gen Xers are now 60. So how prepared will they be to thrive in the decades …
قال الدكتور محمد عبد المعطى سمره، عميد المعهد القومى للأورام، إنه لا يوجد طعام واحد محدد قادر على الوقاية من السرطان، كما إنه لا يوجد طعام …
Rising Stars: A strategic marketing lead at CDMO Axplora, Arsalan Khan is also a chemical and pharmaceutical engineer, a published author and an avid tennis player.